Researchers find vitamin D helps the body fight acute respiratory infection.
At a Kennedy School panel on the future of health insurance, the analysts disagreed on many key points, but did agree that any new national plan, if there is one, will take time to create.
Ayelet Waldman stopped at Harvard Law School to talk about her new book, “A Really Good Day: How Microdosing Made a Mega Difference In My Mood, My Marriage, and My Life.”
A study by Harvard Medical School faculty members at Brigham and Women’s Hospital is exploring the health benefits of cocoa in a massive, 18,000-person study that may provide answers hinted at in smaller studies.
Harvard researchers were able, for the first time, to use patients’ own cells to create cells similar to those in bone marrow, and identify potential treatments for a rare blood disorder.
The Gazette speaks with the Medical School's Staci Gruber, who thinks that state marijuana legalization policy has run ahead of science.
A Harvard Chan School researcher has launched a website to connect citizens with data on the water coming through their taps.
Harvard Medical School scientists and colleagues from Massachusetts General Hospital have partly restored hearing in mice with a genetic form of deafness. The new approach overcomes a longstanding barrier to gene therapy for inherited and acquired deafness.
A new study out of Harvard-affiliated Dana-Farber/Boston Children’s Cancer and Blood Disorders Center suggests that precision medicine can provide vital care in treatment and diagnosis of pediatric brain tumors.
Science journalist Gary Taubes brought his “Case Against Sugar” to Harvard Law School.
Sign up for daily emails with the latest Harvard news.
Professor Jennifer Leaning, co-chair of a new committee set up to examine the health consequences of Syria’s civil war, talks about the country’s prospects for stability and recovery.
A new study by researchers at Beth Israel Deaconess Medical Center examines the neuroanatomy behind delusional misidentification syndromes.
Harvard researchers at Massachusetts General Hospital have found a topical chemotherapy and an immune-system-activating compound that is able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial.
Boston has become a safer place for bicyclists as it has improved its infrastructure, a new study from the Harvard T.H. Chan School of Public Health says, with the chances of being injured in a bicycle accident falling 14 percent a year between 2009 and 2012.
A Harvard study has found that women who used ibuprofen or acetaminophen for six years or more were at higher risk of hearing loss than those who used these medications for a year or less.
Cancer patients have new weapons on their side, provided by targeted drug therapy and, more recently, immune therapy. Now, the recent discovery of large numbers of noncoding RNA that are active in disease provides a new opportunity to both understand and fight cancer, according to Pier Paolo Pandolfi, professor at Harvard Medical School and director of the Cancer Center and Cancer Research Institute at Beth Israel Deaconess Medical Center.
A new Harvard center on health and happiness had its academic coming-out party Friday, hosting a daylong symposium that highlighted what science does and doesn’t say about the interaction of health and happiness, and identifying pathways where investigators should probe next.
A panel sponsored by the Harvard Law School’s Food Law and Policy Clinic and the Union of Concerned Scientists brought food luminaries to talk about the need for a national food policy.
Harvard researchers have developed a hydrogel that can be easily injected into blood vessels, helping to stop uncontrolled bleeding even in patients on blood-thinners or with bleeding disorders.
Scientists and ethicists gathered at Harvard Law School to discuss the ethics of human embryo experimentation and whether a two-week developmental time limit on their use is appropriate any longer.
Despite decades of research aimed at understanding suicide, scientists are no better at predicting self-harm than they were a half-century ago.
New research highlights the skill and poise of doctors who tended to stranded crewmen in the famed Shackleton saga.
A new Harvard report addresses legal and ethical factors affecting the health of players in the National Football League, and makes recommendations to improve it.
A new study examines whether lifestyle changes can offset genetic risk of heart disease.
Researchers at Harvard’s Wyss Institute have developed an instrument that smokes cigarettes like a human, and delivers whole smoke to the air space of microfluidic human airway chips. The machine may enable new insights into how nonsmokers and COPD patients respond to smoke.
Restoring the cancer-killing zeal of T cells is being seen as one of the most successful new approaches to cancer treatment in nearly a decade, although researchers note it has shown effectiveness in only about a quarter of cases.
A new approach to manufacturing organs-on-chips developed by Harvard researchers could cut the length and cost of clinical trials significantly.
A Harvard Chan School study suggests that relaxing current U.S. guidelines could provide greater health benefits with less harm and for less money in women who are vaccinated against human papillomavirus.
Leaders from the scientific and business world gathered at Harvard Business School on Oct. 6 to examine regenerative medicine’s scientific and commercial promise.
According to Harvard sociologist Robert Sampson’s theory of “ecology of toxic inequality,” higher lead levels in the blood are often directly tied to racial and ethnic segregation.
By studying women ages 45 to 55, investigators at Harvard-affiliated Brigham and Women’s Hospital have found that reproductive stage, not simply chronological age, may contribute to changes in memory and brain function.
Programs to combat obesity may be aggravating eating disorders and undermining their severity, said experts during a panel discussion hosted by Harvard T.H. Chan School of Public Health.
Chronic myelogenous leukemia (CML) is a slowly progressing type of blood cancer that develops in the bone marrow. Researchers discovered that CML stem cells die in response to inhibition of a protein called Ezh2. Drugs that target the protein are currently being tested in clinical trials for other cancers.
A gene therapy trial points to a healthier future for a young patient suffering from a rare immune disease.
Researchers examined a group of older adults with extraordinary memory performance and found that certain key areas of their brains resembled those of young people.
Scientists at Harvard Medical School and Technion-Israel Institute of Technology have built a giant petri dish to visually demonstrate how bacteria move as they become immune to drugs.
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
Harvard researchers have riddled the role of a molecule key to eruption of the torturous blisters as well as an antibody that interrupts the inflammatory response, opening the way to potential relief for careless hikers.
Campus food experts say the first year in college is a time for change at the dining table as well as in the classroom.
Scientists from Harvard Medical School (HMS) have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.
A Harvard Chan School study has found that drinking-water samples near industrial sites, military fire-training areas, and wastewater-treatment plants have the highest levels of fluorinated compounds, which have been linked with cancer, hormone disruption, high cholesterol, and obesity.
Harvard researchers have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from ALS.
The identification of a molecular compound that combats Huntington’s disease by means of two separate mechanisms may be the watershed moment in the battle against neurodegenerative diseases.
Harvard Professor Charles Lieber and other scientists conducted a study that describes the construction of nanoscale electronic scaffolds that can be seeded with cardiac cells to produce a bionic cardiac patch.
Researchers at Harvard-affiliated Boston Children’s Hospital are looking at new potential avenues for controlling both sepsis and the runaway bacterial infections that provoke it.
A three-decade study conducted by Harvard Chan School lends further support to recent findings on fat intake and long-term health.
Matthew Nock, a psychology professor, talked to the Gazette about a recent federal report showing a sharp rise in suicide in the United States.
Barbara McNeil, health policy expert and longtime faculty member, to serve as interim dean at Harvard Medical School.
An expansive effort by several Harvard-affiliated units and hospitals has created the first cell transplantation center in the Boston area.
Harvard Stem Cell Institute scientists have taken the first steps toward developing a treatment that would make bone marrow-blood stem cell transplantation safer.